Amit Saxena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Amit Saxena has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Krämer
Karolinska Institute 1 Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics Solna, Sweden
1 shared publication - Alf Kastbom
Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
1 shared publication - Ana Coelho
Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Solna, Sweden
1 shared publication Avraham Ben-Nun
Department of Neuroimmunology, Max Planck Institute of Neurobiology, Martinsried, Germany.
1 shared publication- Bingze Xu
Karolinska Institute 1 Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics Solna, Sweden
1 shared publication - Bruce Neil Cronstein
Department of Medicine, Divisions of Rheumatology and Precision Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA
1 shared publication
Latest Publications
- Open Access
- 11 September 2023
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220 (11)
Antigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice
B cells undergo several rounds of selection to eliminate potentially pathogenic autoreactive clones, but in contrast to T cells, evidence of positive selection of autoreactive B cells remains moot. Using unique tetramers, we traced natural autoreactive B cells (C1-B) specific for a defined triple-helical epitope on collagen type-II (COL2), constituting a sizeable fraction of the physiological B cell repertoire in mice, rats, and humans. Adoptive transfer of C1-B suppressed arthritis independently of IL10, separating them from IL10-secreting regulatory B cells. Single-cell sequencing revealed an antigen processing and presentation signature, including induced expression of CD72 and CCR7 as surface markers. C1-B presented COL2 to T cells and induced the expansion of regulatory T cells in a contact-dependent manner. CD72 blockade impeded this effect suggesting a new downstream suppressor mechanism that regulates antigen-specific T cell tolerization. Thus, our results indicate that autoreactive antigen-specific naïve B cells tolerize infiltrating T cells against self-antigens to impede the development of tissue-specific autoimmune inflammation.
- 11 September 2023
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 220 (11)
Open AccessAntigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice
B cells undergo several rounds of selection to eliminate potentially pathogenic autoreactive clones, but in contrast to T cells, evidence of positive selection of autoreactive B cells remains moot. Using unique tetramers, we traced natural autoreactive B cells (C1-B) specific for a defined triple-helical epitope on collagen type-II (COL2), constituting a sizeable fraction of the physiological B cell repertoire in mice, rats, and humans. Adoptive transfer of C1-B suppressed arthritis independently of IL10, separating them from IL10-secreting regulatory B cells. Single-cell sequencing revealed an antigen processing and presentation signature, including induced expression of CD72 and CCR7 as surface markers. C1-B presented COL2 to T cells and induced the expansion of regulatory T cells in a contact-dependent manner. CD72 blockade impeded this effect suggesting a new downstream suppressor mechanism that regulates antigen-specific T cell tolerization. Thus, our results indicate that autoreactive antigen-specific naïve B cells tolerize infiltrating T cells against self-antigens to impede the development of tissue-specific autoimmune inflammation.
- 1 January 2017
- Published by Elsevier
- p. 846-857.e4
Acute Phase Reactants and the Concept of Inflammation
- 1 January 2017
- Published by Elsevier
- p. 846-857.e4
Acute Phase Reactants and the Concept of Inflammation
- 31 May 2009
- Published by Springer Nature in Nature Medicine
- Vol. 15 (6) , 626-632
Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis
Nature Medicine is the premier journal for biomedical research. Respected internationally for the quality of its papers on areas ranging from infectious disease to cancer and neurodegeneration, Nature Medicine aims to bridge the gap between basic research and medical advances and is consistently ranked the number one journal by the Institute of Scientific Investigation in the Medicine, Research and Experimental category.
- 31 May 2009
- Published by Springer Nature in Nature Medicine
- Vol. 15 (6) , 626-632
Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis
Nature Medicine is the premier journal for biomedical research. Respected internationally for the quality of its papers on areas ranging from infectious disease to cancer and neurodegeneration, Nature Medicine aims to bridge the gap between basic research and medical advances and is consistently ranked the number one journal by the Institute of Scientific Investigation in the Medicine, Research and Experimental category.